| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/06/2013 | US8502027 Precise breeding—low acrylamide foods |
| 08/06/2013 | US8501920 Nucleic acid sequences that are shorter than wild-type dystrophin cDNA and that express mini-dystrophin peptides that function in a similar manner as wild-type dystrophin proteins; used to treat muscular distrophy |
| 08/06/2013 | US8501918 Immobilized tumor necrosis factor-α muteins for enhancing immune response in mammals |
| 08/06/2013 | US8501912 Filipil compositions and methods for treating cancer |
| 08/06/2013 | US8501910 Protein sweetener |
| 08/06/2013 | US8501907 Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| 08/06/2013 | US8501707 Mucin antigen vaccine |
| 08/06/2013 | US8501696 Soluble GP130 muteins with improved binding activity |
| 08/06/2013 | US8501694 Method of administering porcine B-domainless fVIII |
| 08/06/2013 | US8501680 Antagonists against interaction of PF4 and RANTES |
| 08/06/2013 | US8501451 Nitrilases and methods for making and using them |
| 08/06/2013 | US8501440 Fibrillation-resistant insulin and insulin analogues |
| 08/06/2013 | US8501439 Method for obtaining active pro-NGF and beta-NGF |
| 08/06/2013 | US8501437 Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials |
| 08/06/2013 | US8501424 Cd4+ epitopes of bone morphogenetic proteins |
| 08/06/2013 | US8501196 Pharmaceutical compositions containing botulinum neurotoxin |
| 08/06/2013 | US8501193 Stabilized Tat antigen and the use thereof for anti-HIV vaccination |
| 08/06/2013 | US8501189 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 08/06/2013 | US8501177 Treatment of ectodermal dysplasia with EDA1 fusion proteins |
| 08/06/2013 | US8501173 Antibodies to high mobility group-1(HMGB1) B-box polypeptides |
| 08/06/2013 | CA2844264A1 Optimized antigens of pneumocystis and use thereof |
| 08/06/2013 | CA2672907C Pegylated pth as pth receptor modulators and uses thereof |
| 08/06/2013 | CA2593866C Synthesis of peptide t-1249 using peptide intermediate fragments |
| 08/06/2013 | CA2593864C Synthesis using peptide intermediate fragments iii |
| 08/06/2013 | CA2582462C Prion protein binding materials and methods of use |
| 08/06/2013 | CA2571287C Improved corn fractionation method |
| 08/06/2013 | CA2564784C Episomal fusion gene |
| 08/06/2013 | CA2564179C Biologically active peptide vapeehptllteaplnpk derivatives |
| 08/06/2013 | CA2552756C Mouse model for psoriasis and psoriatic arthritis |
| 08/06/2013 | CA2542478C Method for the dissociation of the extracellular haemoglobin molecule of arenicola marina and the characterisation of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains |
| 08/06/2013 | CA2529660C Vegf traps and therapeutic uses thereof |
| 08/06/2013 | CA2425779C Compositions that inhibit proliferation of cancer cells |
| 08/06/2013 | CA2371929C Fab'-epitope complex from the hiv-1 cross-neutralizing monoclonal antibody 2f5 |
| 08/06/2013 | CA2358385C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 08/06/2013 | CA2329684C Cyclin-dependent kinase inhibitors as plant growth regulators |
| 08/06/2013 | CA2238289C Biocontrol agent and fungicide for blackleg disease |
| 08/01/2013 | WO2013112995A1 Influenza c virus and vaccine |
| 08/01/2013 | WO2013112912A1 Peptide antagonists of the calcitonin cgrp family of peptide hormones and their use |
| 08/01/2013 | WO2013112867A1 Vaccines against clostridium difficile comprising recombinant toxins |
| 08/01/2013 | WO2013112834A1 Compositions and methods for treating infections |
| 08/01/2013 | WO2013112595A2 Methods and compositions for gene editing of a pathogen |
| 08/01/2013 | WO2013111759A1 Collagen-like peptide having stealth property and high urinary excretion property |
| 08/01/2013 | WO2013111515A1 Method for inducing/activating cardiac stem/progenitor cell using specific factor |
| 08/01/2013 | WO2013111448A1 Human papilloma virus type 16l1-derived b cell epitope peptide |
| 08/01/2013 | WO2013110837A1 Haptens, conjugates and antibodies for pyrimethanil fungicide |
| 08/01/2013 | WO2013110818A2 Immunogens for hiv vaccination |
| 08/01/2013 | WO2013110790A1 Vaccine compositions for hiv prevention and treatment |
| 08/01/2013 | WO2013110191A1 Abc trepenoid transporters and methods of using the same |
| 08/01/2013 | WO2013110163A1 Compositions and methods of modulating an immune response |
| 08/01/2013 | WO2013110132A1 Method of producing biosurfactants |
| 08/01/2013 | WO2013083858A9 Compounds suitable for treatment of haemophilia |
| 08/01/2013 | WO2013083781A3 Biomarkers and test panels useful in systemic inflammatory conditions |
| 08/01/2013 | WO2013080134A3 Anti-fh aptamers, method for producing same, and uses thereof |
| 08/01/2013 | WO2013080051A3 Methods of enhancing genetic diagnosis using a cell culture substrate comprising laminin and cadherin |
| 08/01/2013 | WO2013072914A3 Plant rad52 and uses thereof |
| 08/01/2013 | WO2013068602A3 Method for the production of polypeptides |
| 08/01/2013 | WO2013054199A3 Cmv antigens and uses thereof |
| 08/01/2013 | WO2013053857A3 Gene cluster for biosynthesis of griselimycin and methylgriselimycin |
| 08/01/2013 | WO2013048222A3 Peptide for synthesizing silica, and use thereof |
| 08/01/2013 | WO2013043013A3 Composition containing complex cytokines derived from ebv-infected b cells for inducing the maturation of dendritic cells |
| 08/01/2013 | WO2013030840A3 Adhesive biopolymers and uses thereof |
| 08/01/2013 | WO2012156958A8 Cell line of lymphocytes comprising gamma-delta t cells, composition and production method thereof |
| 08/01/2013 | WO2008028501A8 Methods for blocking the interaction between nkp80 and its ligand aicl |
| 08/01/2013 | US20130198907 Protein for Use in Modifying Abiotic Stress Tolerance in Yeast |
| 08/01/2013 | US20130198886 Chloroplast transit peptides for efficient targeting of dmo and uses thereof |
| 08/01/2013 | US20130197196 Protein production |
| 08/01/2013 | US20130197194 Spider silk based matrix |
| 08/01/2013 | US20130197192 Method and Composition for Crystallizing G Protein-Coupled Receptors |
| 08/01/2013 | US20130197191 Binding Proteins That Bind to Human FGFR1c, Human Beta-Klotho and Both Human FGFR1c and Human Beta-Klotho |
| 08/01/2013 | US20130197102 3d matrices of human elastin-like polipeptides and method of preparation thereof |
| 08/01/2013 | US20130196933 Methods and Compositions Inhibiting Tumor Cell Proliferation |
| 08/01/2013 | US20130196932 Frataxin Mutants |
| 08/01/2013 | US20130196931 Means and methods for counteracting protein aggregation |
| 08/01/2013 | US20130196930 Polynucleotides encoding recombinant lubricin molecules and uses thereof |
| 08/01/2013 | US20130196929 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 08/01/2013 | US20130196928 Library from toxin mutants and methods of using same |
| 08/01/2013 | US20130196926 Controlled release of ocular biopharmaceuticals using bioresponsive protein polymers |
| 08/01/2013 | US20130196925 Compositions and methods useful in enhancement of memory |
| 08/01/2013 | US20130196923 Novel peptides which have analgesic effects and which inhibit asic channels |
| 08/01/2013 | US20130196922 Bnip3 isoforms and methods of use |
| 08/01/2013 | US20130196920 Process for production of bivalirudin |
| 08/01/2013 | US20130196919 Process for production of bivalirudin |
| 08/01/2013 | US20130196916 Process for production of bivalirudin |
| 08/01/2013 | US20130196913 Gip analog and hybrid polypeptides with selectable properties |
| 08/01/2013 | US20130196912 Beta thymosin fragments |
| 08/01/2013 | US20130196910 Bmp-4 peptides and methods of use |
| 08/01/2013 | US20130196909 BMP-7 Peptides and Methods of Use |
| 08/01/2013 | US20130196901 Neisseria Porin Protiens |
| 08/01/2013 | US20130196871 Fibronectin Binding Domains with Reduced Immunogenicity |
| 08/01/2013 | US20130196427 Cancer antigen peptides derived from wt1 |
| 08/01/2013 | US20130196412 Magi polynucleotides, polypetides, and antibodies |
| 08/01/2013 | US20130196376 Method for the High Level Expression of Active Lymphotoxin-Beta Receptor Immunoglobulin Chimeric Proteins and Their Purification |
| 08/01/2013 | US20130196373 Modified dna-binding proteins and uses thereof |
| 08/01/2013 | US20130196329 IDENTIFICATION OF ISOLATED GENOMIC NUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN ACHAETE-SCUTE HOMOLOG 2 (HASH2) AND VARIANTS THEREOF |
| 08/01/2013 | US20130196314 Genes Differentially Expressed in Breast Cancer |
| 08/01/2013 | US20130196011 Antimicrobial bacteria strains and uses thereof |
| 08/01/2013 | US20130195909 Composite Antigenic Sequences and Vaccines |
| 08/01/2013 | US20130195905 Composition for Preventing or Treating Cervical Cancer Having Human Papillomavirus Plasmodium and Immunity Enhancer |
| 08/01/2013 | US20130195902 Recombinant allergen |
| 08/01/2013 | US20130195895 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |